BioStock Feed

2026-11-03 15:44:00 BioVal™ analysis of SynAct’s resomelagon – three indications with a combined value of SEK 2.9B

2026-11-03 15:44:00 BioVal™-analys av SynActs resomelagon – tre indikationer med ett kombinerat värde om 2,9 miljarder kronor

2026-11-03 14:02:00 SynAct sharpens its phase III plans for resomelagon

2026-10-29 10:59:00 BioStock publicerar Consensus Analysis för Getinge

2026-10-28 10:44:00 SynAct on signing resomelagon’s first commercial partner

2026-10-14 14:06:00 Pila Pharma doses first participants in obesity trial with oral TRPV1 antagonist

2026-10-14 14:06:00 Pila Pharma doserar första deltagarna i fetmastudie med oral TRPV1-antagonist

2026-10-07 10:03:00 FluoGuide enrols first patient in US brain cancer trial

2026-10-06 11:24:00 Curasight continues its glioblastoma trial following approval of updated protocol

2026-10-02 11:03:00 BioStock publishes the Q3 2026 edition of State of Nordic Biopharma

2026-10-02 11:03:00 BioStock publicerar Q3 2026-utgåvan av State of Nordic Biopharma

2026-10-01 14:41:00 Obesity trial gets underway for Pila Pharma

2026-10-01 14:41:00 Obesitasstudie inleds för Pila Pharma

2026-09-24 12:21:00 Video from Initiator Pharma's presentation at BioStock Investing in Life Science 2026

2026-09-24 12:18:00 Video from SynAct Pharma's presentation at BioStock Investing in Life Science 2026

2026-09-24 11:30:00 Video from Initiator Pharma's presentation at BioStock Investing in Life Science 2026

2026-09-24 10:56:00 Video from SynAct Pharma's presentation at BioStock Investing in Life Science 2026

2026-09-24 10:21:00 Video from FluoGuide's presentation at BioStock Investing in Life Science 2026

2026-09-17 16:11:00 SynAct’s CSO on resomelagon making WHO’s dengue shortlist

2026-09-15 14:54:00 OncoZenge om företrädesemissionen och vägen framåt

2026-09-14 12:30:00 BioStock publicerar Consensus Analysis för Ascendis Pharma

2026-09-10 09:05:00 Cinclus Pharma to Present at Investing in Life Science on September 22

2026-09-10 09:05:00 Cinclus Pharma presenterar på Investing in Life Science 22 september

2026-09-10 09:00:00 Cantargia to Present at Investing in Life Science on September 22

2026-09-10 09:00:00 Cantargia presenterar på Investing in Life Science 22 september

2026-09-10 09:00:00 Initiator Pharma presenterar på Investing in Life Science 22 september

2026-09-10 09:00:00 Initiator Pharma to Present at Investing in Life Science on September 22

2026-09-10 09:00:00 Gasporox to Present at Investing in Life Science on September 22

2026-09-10 09:00:00 Annexin Pharmaceuticals to Present at Investing in Life Science on September 22

2026-09-10 09:00:00 Biovica presenterar på Investing in Life Science 22 september

2026-09-10 09:00:00 Biovica to Present at Investing in Life Science on September 22

2026-09-10 09:00:00 OncoZenge to Present at Investing in Life Science on September 22

2026-09-10 09:00:00 Neola Medical to Present at Investing in Life Science on September 22

2026-09-10 09:00:00 Neola Medical presenterar på Investing in Life Science 22 september

2026-09-10 09:00:00 Gasporox presenterar på Investing in Life Science 22 september

2026-09-10 09:00:00 Annexin Pharmaceuticals presenterar på Investing in Life Science 22 september

2026-09-10 09:00:00 Fluoguide to Present at Investing in Life Science on September 22

2026-09-10 09:00:00 OncoZenge presenterar på Investing in Life Science 22 september

2026-09-10 09:00:00 BioInvent International presenterar på Investing in Life Science 22 september

2026-09-10 09:00:00 Fluoguide presenterar på Investing in Life Science 22 september

2026-09-10 09:00:00 BioInvent International to Present at Investing in Life Science on September 22

2026-09-10 09:00:00 SynAct Pharma to Present at Investing in Life Science on September 22

2026-09-10 09:00:00 SynAct Pharma presenterar på Investing in Life Science 22 september

2026-09-08 09:05:00 BioStock publicerar Consensus Analysis för Novonesis

2026-09-07 16:30:00 SynAct on phase III plans following new ADVANCE data

2026-09-01 15:20:00 Saniona’s platform has delivered for others – now it delivers for itself

2026-09-01 13:11:00 BioStock publicerar Consensus Analysis av Coloplast

2026-09-01 09:46:00 Pila Pharma takes the next step toward higher doses in the PP-CT04 study

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode